Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Discover how the breakthrough pill orforglipron matches injectable weight loss drugs in effectiveness while offering ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

Here we present the crystal structure of the glycosylated dimerized hormone-binding domain of the ANP receptor at 2.0-Å resolution. The monomer comprises two interconnected subdomains ...

Considered the natural "hunger hormone," ghrelin could be the key to preventing debilitating chronic constipation experienced ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Auxin is the first plant hormone—or "phytohormone"—ever identified ... and clarified the molecular mechanism by which this protein transports auxin into the cell via the proton concentration ...

These drugs work by increasing the levels of a hormone called GLP-1 (glucagon-like peptide 1), a satiety signal that slows digestion and makes us feel full. Some patients in the UK will be ...